ARTICLE | Company News
BioLineRx, Bar Ilan University, Tel Aviv University deal
May 10, 2004 7:00 AM UTC
BioLineRx received exclusive worldwide rights to compounds that were developed by the universities to treat neurological diseases, including schizophrenia and cancer. The compounds are in research tes...